KArukera Study of Aging in Nursing Homes

Geriatric Syndromes Clinical Trial

— KASEHPAD  

Official title:

Prospective Cohort Study of the Care Pathway for Elderly People in Care in Nursing Homes in Guadeloupe

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT04587466
• Other study ID #: PAP_RIPH3_2020/04
• Secondary ID: 2020-A00960-39
• Status: Recruiting
• Start date: November 3, 2020
• Est. completion date: November 3, 2022

Study information

• Verified date: February 2021
• Source: Centre Hospitalier Universitaire de Pointe-a-Pitre
• Contact: Roxane RV VILLENEUVE, Ph. D
• Phone: +590690403039
• Email: roxane.villeneuve[@]chu-guadeloupe.fr
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

Nursing homes are a recent occurrence in Guadeloupe, and little is known about the characteristics of their residents. In Guadeloupe, in the French West Indies, nearly 1200 dependent older people are cared for in nursing homes. The aim of the KArukera Study of Aging in Nursing Homes (KASEHPAD) is to study the care pathways of dependent elderly people in nursing homes in Guadeloupe over a year. The main objective will be to obtain the annual rate of hospitalisation in this setting. The secondary objectives will be to assess hospitalisations costs, the incidence of mortality, the prevalence of geriatric syndromes, as well as the quality of life of residents and professional caregiver burnout. Ultimately, these results will be compared to a similar study in nursing homes, the KASAF study (for Karukera Study of Aging in Foster Families).

Description:

hile not fully integrated in the Caribbean culture, nursing homes may well become a necessity, and their number is growing. For example, there are now 6 nursing homes in Jamaica, and since the first one in 1991, 20 more have opened in Guadeloupe. Being admitted in a nursing home may be beneficial for the residents as well as for their families since it offers around-the-clock medical care and a secure living environment. On the other hand, living in a nursing home also tend to alter the medical and psychological state of the resident. Little is known about the characteristics of nursing home residents in Guadeloupe. Epidemiological and medico-economic data on older people in nursing homes are essential to assess the relevance of this type of care, and several and yet unanswered questions come to mind: what is the residents' annual hospitalization rate and the associated costs? What is the prevalence of geriatric syndromes in this population, and the incidence of mortality? What is the incidence of pneumonia, the leading cause of death and emergency hospitalization in older people? What is the quality of life of the older residents and their professional caregivers? KASEHPAD, an epidemiological cohort, aims to answer these questions. This longitudinal study will assess the health status and medical and economic data of 500 nursing home residents and their professional caregivers over a year. A similar study (KASAF, for Karukera Study of Aging in Foster Families) will be conducted simultaneously among 250 older people in foster families, as to compare these two types of care. The main outcome is the number of hospitalizations over a year. Local PMSI (Medicalization program of the information system) hospitals databases will provide information on hospital admissions. 500 people aged 60 and older and living in nursing homes in Guadeloupe will be included. Data collection will be conducted using face-to-face interviews with the participants and their professional caregivers at baseline and after 6 and 12 months, and phone interviews with the professional caregivers, after 3 and 9 months. Anthropometric measures, information on general health status and care pathways (hospitalization, medical and paramedical consultations), as well as data on medical history, cognition, nutritional status, and physical frailty will also be collected. Depressive and anxiety symptoms will also be assessed along with functional abilities (mobility, instrumental activities of daily living and activities of daily living). A systematic update of vital status (death) and care pathway will be carried out at each follow-up. Additional information on the residents' living status and potential hospitalizations will be collected after 3 and 9 months. Finally, professional caregivers will be interviewed at inclusion, after 6 months and after a year to assess their own quality of life and burnout symptoms. This study was supported by a grant from the Agence Régionale de Santé de la Guadeloupe.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 500
• Est. completion date: November 3, 2022
• Est. primary completion date: May 3, 2021
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 60 Years and older

Eligibility

Inclusion Criteria:

• participant must be over 60 years old
• residents must live in a nursing home in Guadeloupe, Saint-Martin or Saint-Barthelemy
• residents must benefit from the French social security
• Participant must have an identified support person
• Participant under guardianship or curatorship if accepted by the legal guardian
• Participant in a foreseeable short-term end-of-life situation if accepted by the legal representative or the support person

Exclusion Criteria:

• refusal from the resident or his legal guardian to participate in the study

Related Conditions & MeSH terms

• Geriatric Syndromes
• Syndrome

Locations

Country	Name	City	State
Guadeloupe	Ehpad Residence Sacré Cœur	Basse-Terre
Guadeloupe	Ehpad Kalana	Bouillante
Guadeloupe	Ehpad Nou Gran Moun	Capesterre-Belle-Eau
Guadeloupe	Ehpad Residence Senior 'Les Flamboyants'	Gourbeyre
Guadeloupe	Ehpad St-Christophe	Grand-Bourg
Guadeloupe	Ehpad Domaine de Choisy	Le gosier
Guadeloupe	Ehpad Ch Jacques Salin	Les Abymes
Guadeloupe	Ehpad Les Jardins de Belost	Saint-Claude
Guadeloupe	Ehpad Res. Medico-Sle de Marie-Galante	Saint-Louis
Guadeloupe	Ehpad Les Roses de Lima	Sainte-Rose
Saint Martin	Ehpad Bethany Home	Saint Martin

Sponsors (2)

Lead Sponsor	Collaborator
Centre Hospitalier Universitaire de Pointe-a-Pitre	Agence Régionale de Santé de la Guadeloupe

Countries where clinical trial is conducted

Guadeloupe,  Saint Martin, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Other	Medical consultations of the participant	Number of consultations with a general practitioner, a medical specialist or paramedical professional will be collected.; This information will be retrieved from the CRF using the RUD-Lite scale (Resource Utilization in Dementia questionnaire). This scale assesses the use of healthcare resources by people suffering from dementia. The professional caregiver will complete this questionnaire at inclusion.	inclusion
Other	Medical consultations of the participant	Number of consultations with a general practitioner, a medical specialist or paramedical professional will be collected.; This information will be retrieved from the CRF using the RUD-Lite scale (Resource Utilization in Dementia questionnaire). This scale assesses the use of healthcare resources by people suffering from dementia. The professional caregiver will complete this questionnaire at the 3-month follow-up.	3 months
Other	Medical consultations of the participant	Number of consultations with a general practitioner, a medical specialist or paramedical professional will be collected.; This information will be retrieved from the CRF using the RUD-Lite scale (Resource Utilization in Dementia questionnaire). This scale assesses the use of healthcare resources by people suffering from dementia. The professional caregiver will complete this questionnaire at the 6-month follow-up.	6 months
Other	Medical consultations of the participant	Number of consultations with a general practitioner, a medical specialist or paramedical professional will be collected.; This information will be retrieved from the CRF using the RUD-Lite scale (Resource Utilization in Dementia questionnaire). This scale assesses the use of healthcare resources by people suffering from dementia. The professional caregiver will complete this questionnaire at the 9-month follow-up.	9 months
Other	Medical consultations of the participant	Number of consultations with a general practitioner, a medical specialist or paramedical professional will be collected.; This information will be retrieved from the CRF using the RUD-Lite scale (Resource Utilization in Dementia questionnaire). This scale assesses the use of healthcare resources by people suffering from dementia. The professional caregiver will complete this questionnaire at the 12-month follow-up.	12 months
Other	Global cost of hospitalization of the participant	Global cost of hospitalization will be retrieved from the local PMSI (Medicalization program of the information system) databases after study completion	12 months
Other	Vital status of the participant	Vital status (alive or deceased) will be collected at the 3-month follow-up from the professional caregiver.	3 months
Other	Vital status of the participant	Vital status (alive or deceased) will be collected at the 6-month follow-up from the professional caregiver.	6 months
Other	Vital status of the participant	Vital status (alive or deceased) will be collected at the 9-month follow-up , from the professional caregiver.	9 months
Other	Vital status of the participant	Vital status (alive or deceased) will be collected at the 12-month follow-up , from the professional caregiver.	12 months
Other	Lower respiratory tract infections of the participant	Occurrence of lower respiratory tract infections will be collected using the RUD-lite. For the diagnosis of lower respiratory tract infections, at least two of the following must be present and a doctor must confirm the clinical evidence: Cough (starting or worsening) that may produce phlegm, specific clinical signs during auscultation; Fever. (=38°C); Chest pain ; Rapid, shallow breathing ((=25 per minute) ; Confusion or increased dependency.; The professional caregiver will complete this question at inclusion.	inclusion
Other	Lower respiratory tract infections of the participant	Occurrence of lower respiratory tract infections will be collected using the RUD-lite. For the diagnosis of lower respiratory tract infections, at least two of the following must be present and a doctor must confirm the clinical evidence: Cough (starting or worsening) that may produce phlegm, specific clinical signs during auscultation; Fever. (=38°C); Chest pain ; Rapid, shallow breathing ((=25 per minute) ; Confusion or increased dependency.; The professional caregiver will complete this question at the 3-month follow-up.	3 months
Other	Lower respiratory tract infections of the participant	Occurrence of lower respiratory tract infections will be collected using the RUD-lite. For the diagnosis of lower respiratory tract infections, at least two of the following must be present and a doctor must confirm the clinical evidence: Cough (starting or worsening) that may produce phlegm, specific clinical signs during auscultation; Fever. (=38°C); Chest pain ; Rapid, shallow breathing ((=25 per minute) ; Confusion or increased dependency.; The professional caregiver will complete this question at the 6-month follow-up.	6 months
Other	Lower respiratory tract infections of the participant	Occurrence of lower respiratory tract infections will be collected using the RUD-lite. For the diagnosis of lower respiratory tract infections, at least two of the following must be present and a doctor must confirm the clinical evidence: Cough (starting or worsening) that may produce phlegm, specific clinical signs during auscultation; Fever. (=38°C); Chest pain ; Rapid, shallow breathing ((=25 per minute) ; Confusion or increased dependency.; The professional caregiver will complete this question at the 9-month follow-up.	9 months
Other	Lower respiratory tract infections of the participant	Occurrence of lower respiratory tract infections will be collected using the RUD-lite. For the diagnosis of lower respiratory tract infections, at least two of the following must be present and a doctor must confirm the clinical evidence: Cough (starting or worsening) that may produce phlegm, specific clinical signs during auscultation; Fever. (=38°C); Chest pain ; Rapid, shallow breathing ((=25 per minute) ; Confusion or increased dependency.; The professional caregiver will complete this question at at the 12-month follow-up.	12 months
Other	Falls of the participant	Total number of falls since the last visit will be collected at the 6-month follow-up from the professional caregivers.	6 months
Other	Falls of the participant	Total number of falls since the last visit will be collected at the 12-month follow-up from the professional caregivers.	12 months
Other	Cognition of the participant	The level of cognitive deterioration of the participants will be with the Mini Mental State Examination (MMSE). This 30-item scale assesses the severity of cognitive deterioration through items of orientation, learning, attention and arithmetic, memory, language, and constructive praxis.; The scale is rated from 0 to 30, reflecting the level of cognitive impairment. The participant will complete this questionnaire at inclusion.	inclusion
Other	Cognition of the participant	The level of cognitive deterioration of the participants will be with the Mini Mental State Examination (MMSE). This 30-item scale assesses the severity of cognitive deterioration through items of orientation, learning, attention and arithmetic, memory, language, and constructive praxis.; The scale is rated from 0 to 30, reflecting the level of cognitive impairment. The participant will complete this questionnaire at the 6-month follow-up.	6 months
Other	Cognition of the participant	The level of cognitive deterioration of the participants will be with the Mini Mental State Examination (MMSE). This 30-item scale assesses the severity of cognitive deterioration through items of orientation, learning, attention and arithmetic, memory, language, and constructive praxis.; The scale is rated from 0 to 30, reflecting the level of cognitive impairment. The participant will complete this questionnaire at the 12-month follow-up.	12 months
Other	Depressive symptoms of the participant	Depressive symptoms will be assessed using the CES-D (Center for Epidemiologic Studies- Depression Scale validated in French by Fuhrer & Rouillon This 20-item questionnaire assesses depressive symptomatology, including 4 items on positive affect (happiness, self-worth, confidence, enjoyment). Frequency of symptom occurrence during the past week is assessed by the participant using a 4-point Likert scale ("never", "occasionally", "quite often" and "frequently"). The score ranges from 0 to 60. The higher the score, the more significant the symptomatology. Data will be collected at inclusion, T6 and T12. For statistical analyses, the variable will be dichotomized (1 = presence of depression and 0 = absence of depression). The participant will complete this questionnaire at inclusion.	inclusion
Other	Depressive symptoms of the participant	Depressive symptoms will be assessed using the CES-D (Center for Epidemiologic Studies- Depression Scale validated in French by Fuhrer & Rouillon This 20-item questionnaire assesses depressive symptomatology, including 4 items on positive affect (happiness, self-worth, confidence, enjoyment). Frequency of symptom occurrence during the past week is assessed by the participant using a 4-point Likert scale ("never", "occasionally", "quite often" and "frequently"). The score ranges from 0 to 60. The higher the score, the more significant the symptomatology. Data will be collected at inclusion, T6 and T12. For statistical analyses, the variable will be dichotomized (1 = presence of depression and 0 = absence of depression). The participant will complete this questionnaire at the 6-month follow-up	6 months
Other	Depressive symptoms of the participant	Depressive symptoms will be assessed using the CES-D (Center for Epidemiologic Studies- Depression Scale validated in French by Fuhrer & Rouillon This 20-item questionnaire assesses depressive symptomatology, including 4 items on positive affect (happiness, self-worth, confidence, enjoyment). Frequency of symptom occurrence during the past week is assessed by the participant using a 4-point Likert scale ("never", "occasionally", "quite often" and "frequently"). The score ranges from 0 to 60. The higher the score, the more significant the symptomatology. Data will be collected at inclusion, T6 and T12. For statistical analyses, the variable will be dichotomized (1 = presence of depression and 0 = absence of depression). The participant will complete this questionnaire at the 12-month follow-up.	12 months
Other	Feeling of loneliness of the participant	Feeling of loneliness will be captured with the 14th item of the CES-D (14, 15): " I felt lonely ". The participant will complete this test at inclusion.	inclusion
Other	Feeling of loneliness of the participant	Feeling of loneliness will be captured with the 14th item of the CES-D (14, 15): " I felt lonely ". The participant will complete this test at the 6-month follow-up.	6 months
Other	Feeling of loneliness of the participant	Feeling of loneliness will be captured with the 14th item of the CES-D (14, 15): " I felt lonely ". The participant will complete this test at the 12-month follow-up.	12 months
Other	Polypharmacy of the participant	Total number of medications taken by participants will be collected from the professional caregiver at inclusion to assess polypharmacy.	inclusion
Other	Polypharmacy of the participant	Total number of medications taken by participants will be collected from the professional caregiver at the 6-month follow-up to assess polypharmacy.	6 months
Other	Polypharmacy of the participant	Total number of medications taken by participants will be collected from the professional caregiver at the 12-month follow-up to assess polypharmacy.	12 months
Other	Malnutrition of the participant	Malnutrition will be assessed with the short version of the Mini Nutritional Assessment (18). This questionnaire assesses nutritional status. A score under 12 indicates probable undernutrition. For the analyses, the variable will be dichotomized accordingly (1 = undernutrition; 0 = no undernutrition). The participant will complete this questionnaire at inclusion.	inclusion
Other	Malnutrition of the participant	Malnutrition will be assessed with the short version of the Mini Nutritional Assessment (18). This questionnaire assesses nutritional status. A score under 12 indicates probable undernutrition. For the analyses, the variable will be dichotomized accordingly (1 = undernutrition; 0 = no undernutrition). The participant will complete this questionnaire at the 6-month follow-up.	6 months
Other	Malnutrition of the participant	Malnutrition will be assessed with the short version of the Mini Nutritional Assessment (18). This questionnaire assesses nutritional status. A score under 12 indicates probable undernutrition. For the analyses, the variable will be dichotomized accordingly (1 = undernutrition; 0 = no undernutrition). The participant will complete this questionnaire at the 12-month follow-up.	12 months
Other	Sarcopenia of the participant	The Short Physical Performance Battery (SPPB) will help to identify sarcopenia. Three subtests measure lower-extremity functions: keeping balance (feet side-by-side, semi-tandem, tandem balance position, to be kept for 10 seconds each), walking 4 meters at usual pace, yielding a gait speed ratio (meter per second) ; standing up and sitting down five times as quickly as possible with the arms folded. Each movement is scored 0-4 points out of a total score from 0 to 12, with higher scores showing better physical performance. If total score is under 8, there is a risk of sarcopenia. For the analyses, the variable will be dichotomized accordingly (1 = sarcopenia; 0 = no sarcopenia). The participant will complete this test at inclusion.	inclusion
Other	Sarcopenia of the participant	The Short Physical Performance Battery (SPPB) will help to identify sarcopenia. Three subtests measure lower-extremity functions: keeping balance (feet side-by-side, semi-tandem, tandem balance position, to be kept for 10 seconds each), walking 4 meters at usual pace, yielding a gait speed ratio (meter per second) ; standing up and sitting down five times as quickly as possible with the arms folded. Each movement is scored 0-4 points out of a total score from 0 to 12, with higher scores showing better physical performance. If total score is under 8, there is a risk of sarcopenia. For the analyses, the variable will be dichotomized accordingly (1 = sarcopenia; 0 = no sarcopenia). The participant will complete this test at the 6-month follow-up.	6 months
Other	Sarcopenia of the participant	The Short Physical Performance Battery (SPPB) will help to identify sarcopenia. Three subtests measure lower-extremity functions: keeping balance (feet side-by-side, semi-tandem, tandem balance position, to be kept for 10 seconds each), walking 4 meters at usual pace, yielding a gait speed ratio (meter per second) ; standing up and sitting down five times as quickly as possible with the arms folded. Each movement is scored 0-4 points out of a total score from 0 to 12, with higher scores showing better physical performance. If total score is under 8, there is a risk of sarcopenia. For the analyses, the variable will be dichotomized accordingly (1 = sarcopenia; 0 = no sarcopenia). The participant will complete this test at the 12-month follow-up.	12 months
Other	Frailty of the participant	Frailty will be assessed at inclusion, T6 and T12 using Fried's phenotype (weight loss, exhaustion, low physical activity, slowness, weakness) and will be analyzed as a dichotomous variable, i.e. 1 = Fragile and 0 = Not Fragile. Information on the different components of the phenotype will be retrieved from the MNA, the SPPB and a hand-grip strength test using a dynamometer, at inclusion.	inclusion
Other	Frailty of the participant	Frailty will be assessed at inclusion, T6 and T12 using Fried's phenotype (weight loss, exhaustion, low physical activity, slowness, weakness) and will be analyzed as a dichotomous variable, i.e. 1 = Fragile and 0 = Not Fragile. Information on the different components of the phenotype will be retrieved from the MNA, the SPPB and a hand-grip strength test using a dynamometer, at the 6-month follow-up.	6 months
Other	Frailty of the participant	Frailty will be assessed at inclusion, T6 and T12 using Fried's phenotype (weight loss, exhaustion, low physical activity, slowness, weakness) and will be analyzed as a dichotomous variable, i.e. 1 = Fragile and 0 = Not Fragile. Information on the different components of the phenotype will be retrieved from the MNA, the SPPB and a hand-grip strength test using a dynamometer, at the 12-month follow-up.	12 months
Other	Sensory impairment of the participant	Sensory impairments (audition and vision) will be addressed by directly asking the professional caregiver. Variables will be dichotomized accordingly ((1 = hearing / vision impairment; 0 = hearing / vision impairment). The professional caregiver will complete this questionnaire at inclusion.	inclusion
Other	Sensory impairment of the participant	Sensory impairments (audition and vision) will be addressed by directly asking the professional caregiver. Variables will be dichotomized accordingly ((1 = hearing / vision impairment; 0 = hearing / vision impairment). The professional caregiver will complete this questionnaire at the 6-month follow-up.	6 months
Other	Sensory impairment of the participant	Sensory impairments (audition and vision) will be addressed by directly asking the professional caregiver. Variables will be dichotomized accordingly ((1 = hearing / vision impairment; 0 = hearing / vision impairment). TThe professional caregiver will complete this questionnaire at the 12-month follow-up.	12 months
Other	Activities of Daily Living of the participant	The level of independence in Activities of Daily Living (ADL) and incontinence will be assessed using the Katz's scale, a 6-item scale assessing independence in 6 basic activities of daily living: bathing, toileting, eating, dressing, incontinence. For each activity, a score of 1 indicates complete autonomy, a score of 0.5 indicates partial autonomy, and a score of 0 indicates complete dependency. The professional caregiver will complete this questionnaire about the participant at inclusion.	inclusion
Other	Activities of Daily Living of the participant	The level of independence in Activities of Daily Living (ADL) and incontinence will be assessed using the Katz's scale, a 6-item scale assessing independence in 6 basic activities of daily living: bathing, toileting, eating, dressing, incontinence. For each activity, a score of 1 indicates complete autonomy, a score of 0.5 indicates partial autonomy, and a score of 0 indicates complete dependency. The professional caregiver will complete this questionnaire about the participant at the 6-month follow-up.	6 months
Other	Activities of Daily Living of the participant	The level of independence in Activities of Daily Living (ADL) and incontinence will be assessed using the Katz's scale, a 6-item scale assessing independence in 6 basic activities of daily living: bathing, toileting, eating, dressing, incontinence. For each activity, a score of 1 indicates complete autonomy, a score of 0.5 indicates partial autonomy, and a score of 0 indicates complete dependency. The professional caregiver will complete this questionnaire about the participant at the 12-month follow-up.	12 months
Other	Instrumental Activities of Daily Living of the participant	The level of independence in Instrumental Activities of Daily Living (IADL) will be assessed using Lawton's IADL scale. The professional caregiver will complete this questionnaire about the participant at inclusion.	inclusion
Other	Instrumental Activities of Daily Living of the participant	The level of independence in Instrumental Activities of Daily Living (IADL) will be assessed using Lawton's IADL scale. The professional caregiver will complete this questionnaire about the participant at the 6-month follow-up.	6 months
Other	Instrumental Activities of Daily Living of the participant	The level of independence in Instrumental Activities of Daily Living (IADL) will be assessed using Lawton's IADL scale. The professional caregiver will complete this questionnaire about the participant at the 12-month follow-up.	12 months
Other	Dependency of the participant	In France, the AGGIR questionnaire has been developed by public authorities to quickly assess the degree of dependency of elderly people, and assign a dependency group, ranging from 0 (bedridden, completely dependent) to 6 (no help required, the person is autonomous in everyday activities.) This scale is routinely completed by every nursing home at admission and updated when necessary to reassess healthcare pathways. The professional caregiver will complete this questionnaire about the participant at inclusion.	inclusion
Other	Dependency of the participant	In France, the AGGIR questionnaire has been developed by public authorities to quickly assess the degree of dependency of elderly people, and assign a dependency group, ranging from 0 (bedridden, completely dependent) to 6 (no help required, the person is autonomous in everyday activities.) This scale is routinely completed by every nursing home at admission and updated when necessary to reassess healthcare pathways. The professional caregiver will complete this questionnaire about the participant at the 6-month follow-up.	6 months
Other	Dependency of the participant	In France, the AGGIR questionnaire has been developed by public authorities to quickly assess the degree of dependency of elderly people, and assign a dependency group, ranging from 0 (bedridden, completely dependent) to 6 (no help required, the person is autonomous in everyday activities.) This scale is routinely completed by every nursing home at admission and updated when necessary to reassess healthcare pathways. The professional caregiver will complete this questionnaire about the participant at at the 12-month follow-up.	12 months
Other	Psychological and Behavioral Symptoms in Dementia of the participant	Psychological and Behavioral Symptoms in Dementia will be assessed with the short version of the NeuroPsychiatric Inventory or NPI. This scale assesses presence, severity for the patient and impact on the professional's workload of an array of psychological and behavioral manifestations (agitation, hallucinations, apathy, etc.) as well as neurovegetative symptoms (sleep and appetite). The professional caregiver will complete this questionnaire about the participant at inclusion.	inclusion
Other	Psychological and Behavioral Symptoms in Dementia of the participant	Psychological and Behavioral Symptoms in Dementia will be assessed with the short version of the NeuroPsychiatric Inventory or NPI. This scale assesses presence, severity for the patient and impact on the professional's workload of an array of psychological and behavioral manifestations (agitation, hallucinations, apathy, etc.) as well as neurovegetative symptoms (sleep and appetite). The professional caregiver will complete this questionnaire about the participant at the 6-month follow-up.	6 months
Other	Psychological and Behavioral Symptoms in Dementia of the participant	Psychological and Behavioral Symptoms in Dementia will be assessed with the short version of the NeuroPsychiatric Inventory or NPI. This scale assesses presence, severity for the patient and impact on the professional's workload of an array of psychological and behavioral manifestations (agitation, hallucinations, apathy, etc.) as well as neurovegetative symptoms (sleep and appetite). The professional caregiver will complete this questionnaire about the participant at the 12-month follow-up.	12 months
Other	Risk of developing pressure ulcers of the participant	Risk of developing pressure ulcers will be assessed with the Braden's Scale, and pressure ulcers will be classified according to the National Pressure Ulcer Advisory Panel, European Pressure Ulcer Advisory Panel and Pan Pacific Pressure Injury Alliance. The professional caregiver will complete this questionnaire about the participant at inclusion.	inclusion
Other	Risk of developing pressure ulcers of the participant	Risk of developing pressure ulcers will be assessed with the Braden's Scale, and pressure ulcers will be classified according to the National Pressure Ulcer Advisory Panel, European Pressure Ulcer Advisory Panel and Pan Pacific Pressure Injury Alliance. The professional caregiver will complete this questionnaire about the participant at the 6-month follow-up.	6 months
Other	Risk of developing pressure ulcers of the participant	Risk of developing pressure ulcers will be assessed with the Braden's Scale, and pressure ulcers will be classified according to the National Pressure Ulcer Advisory Panel, European Pressure Ulcer Advisory Panel and Pan Pacific Pressure Injury Alliance. The professional caregiver will complete this questionnaire about the participant at the 12-month follow-up.	12 months
Other	Quality of life of the participant	Quality of life of the participant will be assessed using the QoL-AD (Questionnaire Quality of Life - Alzheimer's Disease). This 13-item questionnaire assesses the participant's physical condition, mood, relationships with friends and family, financial difficulties, and overall quality of life. The self-rated and the proxy-rated version of the questionnaire will be administered to the participant and the caregiver, respectively. The items are evaluated using a 4-point ordinal scale ranging from poor to excellent, with a total score ranging from 13 to 52. For the weighted score, the participant's score is multiplied by 2, the caregiver's score (about the participant's quality of life) is added, and the total is divided by 3 to bring the score back to the initial scale. The participant and the professional caregiver will complete this test at inclusion.	inclusion
Other	Quality of life of the participant	Quality of life of the participant will be assessed using the QoL-AD (Questionnaire Quality of Life - Alzheimer's Disease). This 13-item questionnaire assesses the participant's physical condition, mood, relationships with friends and family, financial difficulties, and overall quality of life. The self-rated and the proxy-rated version of the questionnaire will be administered to the participant and the caregiver, respectively. The items are evaluated using a 4-point ordinal scale ranging from poor to excellent, with a total score ranging from 13 to 52. For the weighted score, the participant's score is multiplied by 2, the caregiver's score (about the participant's quality of life) is added, and the total is divided by 3 to bring the score back to the initial scale. The participant and the professional caregiver will complete this test at the 6-month follow-up.	6 months
Other	Quality of life of the participant	Quality of life of the participant will be assessed using the QoL-AD (Questionnaire Quality of Life - Alzheimer's Disease). This 13-item questionnaire assesses the participant's physical condition, mood, relationships with friends and family, financial difficulties, and overall quality of life. The self-rated and the proxy-rated version of the questionnaire will be administered to the participant and the caregiver, respectively. The items are evaluated using a 4-point ordinal scale ranging from poor to excellent, with a total score ranging from 13 to 52. For the weighted score, the participant's score is multiplied by 2, the caregiver's score (about the participant's quality of life) is added, and the total is divided by 3 to bring the score back to the initial scale. The participant and the professional caregiver will complete this test at the 12-month follow-up.	12 months
Other	Health-related quality of life of the participant	Health-related quality of life of the participant will be assessed with the EQ-5D questionnaire. This questionnaire assesses health conditions. It is the most widely used questionnaire in medico-economic analyses. It allows health outcomes to be assessed in terms of QALYs (Quality-Adjusted Life-Years). This indicator summarizes the length and quality of life in a single figure. The result of a cost-utility analysis is expressed in terms of the cost of gaining one QALY (i.e. one year lived in perfect health). To estimate QALY, health-related quality of life is designed on a continuum from 0 (death) to 1 (perfect health). Each health status is thus assigned a weight of 0 to 1, the higher the corresponding quality of life.; The participant and the foster caregiver will complete this test at inclusion.	inclusion
Other	Health-related quality of life of the participant	Health-related quality of life of the participant will be assessed with the EQ-5D questionnaire. This questionnaire assesses health conditions. It is the most widely used questionnaire in medico-economic analyses. It allows health outcomes to be assessed in terms of QALYs (Quality-Adjusted Life-Years). This indicator summarizes the length and quality of life in a single figure. The result of a cost-utility analysis is expressed in terms of the cost of gaining one QALY (i.e. one year lived in perfect health). To estimate QALY, health-related quality of life is designed on a continuum from 0 (death) to 1 (perfect health). Each health status is thus assigned a weight of 0 to 1, the higher the corresponding quality of life.; The participant and the foster caregiver will complete this test at the 6-month follow-up.	6 months
Other	Health-related quality of life of the participant	Health-related quality of life of the participant will be assessed with the EQ-5D questionnaire. This questionnaire assesses health conditions. It is the most widely used questionnaire in medico-economic analyses. It allows health outcomes to be assessed in terms of QALYs (Quality-Adjusted Life-Years). This indicator summarizes the length and quality of life in a single figure. The result of a cost-utility analysis is expressed in terms of the cost of gaining one QALY (i.e. one year lived in perfect health). To estimate QALY, health-related quality of life is designed on a continuum from 0 (death) to 1 (perfect health). Each health status is thus assigned a weight of 0 to 1, the higher the corresponding quality of life.; The participant and the foster caregiver will complete this test at the 12-month follow-up.	12 months
Other	Adaptation to the nursing home of the participant	Adaptation to the professional family will be assessed using Castonguay & Ferron's scale. This is a 17-item scale designed to identify people who have difficulties to adjust to nursing home life. The participants must answer "yes" or "no" to a series of statements about their daily life and habits in the residence. A score of 16 or 17 indicates a good general adaptation, while a score of 11 or less indicates significant difficulties. The participant and the professional caregiver will complete this test at inclusion.	inclusion
Other	Adaptation to the nursing home of the participant	Adaptation to the professional family will be assessed using Castonguay & Ferron's scale. This is a 17-item scale designed to identify people who have difficulties to adjust to nursing home life. The participants must answer "yes" or "no" to a series of statements about their daily life and habits in the residence. A score of 16 or 17 indicates a good general adaptation, while a score of 11 or less indicates significant difficulties. The participant and the professional caregiver will complete this test at the 6-month follow-up.	6 months
Other	Adaptation to the nursing home of the participant	Adaptation to the professional family will be assessed using Castonguay & Ferron's scale. This is a 17-item scale designed to identify people who have difficulties to adjust to nursing home life. The participants must answer "yes" or "no" to a series of statements about their daily life and habits in the residence. A score of 16 or 17 indicates a good general adaptation, while a score of 11 or less indicates significant difficulties. The participant and the professional caregiver will complete this test at the 12-month follow-up.	12 months
Other	Professional caregivers' quality of life assessed with SF-36	Professional caregivers' quality of life will be assessed with the Medical Outcomes Study Short-Form General Health Survey - 36 items (SF-36, a widely validated health-related quality of life questionnaire, that uses questions on physical, social and psychological domains. The professional caregiver will complete this questionnaire at inclusion.	inclusion
Other	Professional caregivers' quality of life assessed with SF-36	Professional caregivers' quality of life will be assessed with the Medical Outcomes Study Short-Form General Health Survey - 36 items (SF-36, a widely validated health-related quality of life questionnaire, that uses questions on physical, social and psychological domains. The professional caregiver will complete this questionnaire at the 6-month follow-up.	6 months
Other	Professional caregivers' quality of life assessed with SF-36	Professional caregivers' quality of life will be assessed with the Medical Outcomes Study Short-Form General Health Survey - 36 items (SF-36, a widely validated health-related quality of life questionnaire, that uses questions on physical, social and psychological domains. The professional caregiver will complete this questionnaire at the 12-month follow-up.	12 months
Other	Professional caregivers' quality of life assessed with the Pro-QoL scale	Symptoms of burnout will be assessed with the Pro-QoL scale (professional quality of life scale). This 30-item questionnaire yields three domain-specific scores: burnout risk, compassion, and compassion fatigue. The professional caregiver will complete this questionnaire at inclusion.	inclusion
Other	Professional caregivers' quality of life assessed with the Pro-QoL scale	Symptoms of burnout will be assessed with the Pro-QoL scale (professional quality of life scale). This 30-item questionnaire yields three domain-specific scores: burnout risk, compassion, and compassion fatigue. The professional caregiver will complete this questionnaire at the 6-month follow-up.	6 months
Other	Professional caregivers' quality of life assessed with the Pro-QoL scale	Symptoms of burnout will be assessed with the Pro-QoL scale (professional quality of life scale). This 30-item questionnaire yields three domain-specific scores: burnout risk, compassion, and compassion fatigue. The professional caregiver will complete this questionnaire at the 12-month follow-up.	12 months
Primary	Hospitalization rate of the participant	Number of hospital admissions over a year, retrieved from the local PMSI (Medicalization program of the information system) of the Hospital Center of Guadeloupe	12 months
Secondary	Length of hospital stays of the participant	Length of hospital stays expressed as number of days and nights, retrieved from the local PMSI (Medicalization program of the information system) of the Hospital Center of Guadeloupe	12 months